跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Approved
STANDARD
NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Organon Belgium
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 18, 2023
Approval ID
5f910222d8c20d21
Company
Organon Belgium
Type
Standard
Approval Details
Approval Id
5f910222d8c20d21
Drug Cima Aemps Name
NASONEX 50 MICROGRAMOS SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Register Number
BE190854IP2
Holder Company Name
Organon Belgium
Marketing Company Name
Ecofar Productos S.L.
Holder Company Detail Path
/organization/organon-belgium
Authorization Date
2023-08-18
Dosage Form
SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose
50 µg
Route Of Administration
VÍA NASAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Organon Belgium
Company Detail Path
/organization/organon-belgium
Company Information
Pharmaceutical Company Name
Organon Belgium
Country Name
Belgium
City Name
bruxelles,country_be
Address
Rue du Commerce 31
Active Ingredients
MOMETASONA FUROATO
0,05 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 18, 2023
Approval ID
5f910222d8c20d21
Type
Standard
Back to CIMA-AEMPS Approvals